NRX Pharmaceuticals (NRXP)
NASDAQ:NRXP

NRX Pharmaceuticals (NRXP) Stock Investors

294 Followers
Based on 748,626 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold NRXP
On average, investors allocate 0.00% of their portfolios to NRXP
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 748,626 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding NRXP

0.6%
Last 7
Days
3.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding NRXP, out of 748,626 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

NRXP Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
<0.01%
$2.34
Opened
1.79%
$4.38
Increased
0.27%
$7.01
Opened
0.97%
$6.13
Based on the activity of 14,213 investors who made their portfolios public
The table shows changes in NRXP in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

NRXP Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
ChargePoint Holdings
4.22%
-1.39%
-2.72%
820.84M
Consumer Cyclical
AMC Entertainment
5.74%
-1.13%
-3.96%
1.39B
Communication Services
Riot Platforms
5.09%
-0.23%
+0.85%
3.27B
Financial
Blink Charging Co
5.23%
-1.29%
-4.60%
322.38M
Industrials
Lucid Group
5.66%
-1.42%
-3.07%
7.57B
Consumer Cyclical
DraftKings
5.82%
-1.05%
-2.25%
31.47B
Consumer Cyclical
Bristol-Myers Squibb
3.23%
-0.97%
+0.68%
90.53B
Healthcare
Plug Power
5.00%
-1.32%
-3.40%
2.00B
Industrials
Marathon Digital Holdings
5.56%
-0.48%
+0.55%
5.64B
Financial
Merck & Company
3.87%
-0.29%
+3.17%
318.93B
Healthcare
Based on the activity of 748,626 active portfolios
Open your Smart Portfolio

NRXP Investor Analysis

NRXP investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
4.9%
of NRXP holders
are under 35
Average Segment Performance
Average P/E Ratio20.77
Beta7.15
Dividend Yield6.79%
NRXP investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
68.3%
of NRXP holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.59
Beta11.22
Dividend Yield6.44%
NRXP investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
26.8%
of NRXP holders
are over 55
Average Segment Performance
Average P/E Ratio19.41
Beta3.84
Dividend Yield7.80%
Overview of age group and performance of NRXP stock investors
See who invests in NRXP according to age group and performance.

FAQ

How many retail Investors hold NRXP?
<0.1% of TipRanks' retail investors hold NRXP in their portfolios.
    What is NRXP Investor Sentiment?
    NRXP’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of NRXP in the last 7 days?
      ▲ 0.6% of TipRanks' retail investors changed their holding of NRXP in the last 7 days.
        What percentage of retail investors changed their holding of NRXP in the last 30 days?
        ▼ 3.5% of TipRanks' retail investors changed their holding of NRXP in the last 30 days.
          What is the average age of retail investors who hold NRXP?
          The average age of NRXP Holders is between 35–55.
            What other stocks have NRXP investors also bought?
            NRXP Investors also bought CHPT, AMC, RIOT, BLNK, LCID, DKNG, BMY, PLUG, MARA, MRK.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              BAXBaxter International
              BCRXBioCryst
              CRLCharles River Labs
              EWEdwards Lifesciences
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis